Mark E Molitch Selected Research

Hyperprolactinemia

1/2021	Prolactin and Other Pituitary Disorders in Kidney Disease.
9/2020	Dopamine agonists and antipsychotics.
12/2016	Pituitary tumors in MEN1: do not be misled by borderline elevated prolactin levels.
1/2014	Mutant prolactin receptor and familial hyperprolactinemia.
5/2011	Positive prolactin response to bromocriptine in 2 patients with cabergoline-resistant prolactinomas.
4/2010	Pituitary gland: can prolactinomas be cured medically?
1/2008	Drugs and prolactin.
9/2006	Prolactin-secreting tumors: what's new?
8/2006	Advances in the treatment of prolactinomas.
8/2005	Medication-induced hyperprolactinemia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark E Molitch Research Topics

Disease

15	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 09/2006
14	Neoplasms (Cancer) 09/2020 - 01/2003
13	Prolactinoma (Prolactinomas) 09/2020 - 10/2002
13	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 02/2001
13	Hyperglycemia 11/2018 - 09/2006
12	Type 2 Diabetes Mellitus (MODY) 01/2022 - 07/2008
12	Hyperprolactinemia 01/2021 - 10/2002
11	Acromegaly 01/2022 - 08/2003
10	Albuminuria 01/2021 - 12/2002
9	Hypertension (High Blood Pressure) 02/2017 - 08/2003
8	Chronic Renal Insufficiency 01/2021 - 10/2014
7	Infections 01/2021 - 01/2010
7	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020 - 02/2001
7	Pituitary Neoplasms (Pituitary Adenoma) 01/2019 - 08/2003
6	Cushing Syndrome 10/2022 - 08/2003
5	Kidney Diseases (Kidney Disease) 01/2021 - 12/2012
5	Pituitary ACTH Hypersecretion 01/2021 - 08/2003
5	Hypopituitarism (Sheehan's Syndrome) 01/2014 - 01/2007
4	Adrenal Insufficiency (Adrenal Gland Hypofunction) 10/2022 - 06/2015
4	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2021 - 10/2002
4	Weight Loss (Weight Reduction) 12/2018 - 07/2003
4	Diabetes Mellitus 01/2018 - 09/2008
4	Adenoma (Adenomas) 02/2017 - 08/2003
4	Fatigue 02/2016 - 06/2012
4	Weight Gain 06/2014 - 09/2008
3	Galactorrhea 01/2021 - 06/2012
3	Inflammation (Inflammations) 01/2018 - 01/2007
3	Anemia 01/2018 - 01/2014
3	Infertility (Sterility) 02/2017 - 01/2002
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 10/2014
3	Atherosclerosis 01/2017 - 08/2013
3	End Stage Liver Disease 09/2016 - 01/2010
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2015 - 12/2002
3	Insulin Resistance 10/2014 - 07/2008
3	Dyslipidemias (Dyslipidemia) 10/2014 - 09/2006
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2014 - 06/2009
2	Body Weight (Weight, Body) 10/2022 - 12/2018
2	Ketosis 01/2021 - 01/2021
2	Renal Insufficiency (Renal Failure) 01/2021 - 01/2021
2	Hyperthyroidism 02/2017 - 08/2003
2	Amenorrhea 02/2017 - 05/2011
2	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2017 - 08/2003
2	Hirsutism 04/2016 - 06/2015
2	Nausea 04/2016 - 06/2012
2	Spontaneous Abortion (Miscarriage) 05/2015 - 12/2011
2	Autoimmune Diseases (Autoimmune Disease) 01/2007 - 01/2007
1	Muscle Weakness 10/2022

Drug/Important Bio-Agent (IBA)

26	Insulin (Novolin)FDA Link 01/2022 - 11/2006
23	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 12/2002
16	Dopamine Agonists (Dopamine Agonist)IBA 01/2021 - 10/2002
13	ProlactinIBA 01/2021 - 08/2003
12	Testosterone (Sustanon)FDA Link 11/2018 - 10/2002
11	Bromocriptine (Parlodel)FDA LinkGeneric 02/2017 - 01/2002
11	Cabergoline FDA LinkGeneric 02/2017 - 10/2002
9	Hormones (Hormone)IBA 01/2021 - 08/2003
8	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2021 - 01/2004
8	AlbuminsIBA 03/2011 - 02/2001
7	Growth Hormone (Somatotropin)IBA 01/2022 - 08/2003
7	CreatinineIBA 01/2021 - 05/2010
6	Mifepristone (RU 486)FDA Link 10/2022 - 06/2012
5	lanreotide (Somatuline)FDA Link 01/2022 - 01/2008
5	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2021 - 08/2003
5	Hemoglobins (Hemoglobin)IBA 01/2018 - 05/2010
5	Blood Glucose (Blood Sugar)IBA 10/2014 - 09/2006
4	Antipsychotic Agents (Antipsychotics)IBA 09/2020 - 08/2005
4	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 02/2017 - 08/2003
4	Metformin (Glucophage)FDA LinkGeneric 01/2017 - 07/2003
3	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 10/2022 - 06/2012
3	Insulin-Like Growth Factor I (IGF-1)IBA 01/2022 - 06/2010
3	Estrogens (Estrogen)FDA Link 09/2020 - 08/2005
3	LipidsIBA 01/2018 - 01/2006
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 02/2017 - 06/2010
3	Antihypertensive Agents (Antihypertensives)IBA 09/2008 - 08/2005
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2022 - 01/2021
2	Octreotide (Sandostatin)FDA LinkGeneric 01/2022 - 06/2010
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021 - 01/2021
2	Metyrapone FDA Link 01/2021 - 06/2015
2	Uric Acid (Urate)IBA 01/2020 - 01/2019
2	Allopurinol (Remid)FDA LinkGeneric 01/2020 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2017
2	GonadotropinsIBA 01/2018 - 01/2003
2	Insulin-Like PeptidesIBA 02/2017 - 01/2014
2	Insulin Glargine (Lantus)FDA Link 09/2016 - 11/2006
2	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 10/2014 - 10/2014
2	Vitamin D FDA LinkGeneric 08/2013 - 12/2012
2	Triglycerides (Triacylglycerol)IBA 03/2011 - 05/2010
2	LDL CholesterolIBA 03/2011 - 09/2006
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 03/2011 - 07/2010
2	Hemoglobin AIBA 09/2008 - 02/2001
2	Antidepressive Agents (Antidepressants)IBA 01/2008 - 08/2005
2	Pergolide (Permax)FDA Link 01/2005 - 01/2003
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022

Therapy/Procedure

30	Therapeutics 01/2022 - 02/2001
13	Glycemic Control 12/2018 - 12/2002
5	Liver Transplantation 11/2018 - 07/2011
4	Transplantation 11/2018 - 07/2011
3	Radiotherapy 12/2016 - 08/2006
3	Drug Therapy (Chemotherapy) 10/2014 - 06/2011
3	Estrogen Replacement Therapy 05/2014 - 01/2003
2	Length of Stay 10/2018 - 09/2016